New Key Statistics Module, Z-Score and F-Score
GREY:TKUNF Key Ratios
| Market Cap $ M | 9.10 |
| Enterprise Value $ M | 12.63 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.41 |
| Price/Sales | 0.67 |
| Price/Free Cash Flow | 5.51 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 11.00 |
| EPS (TTM) $ | -0.24 |
| Beneish M-Score | -5.89 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.95 |
| EV-to-EBITDA | -2.84 |
| PEG | -- |
| Shares Outstanding M | 84.96 |
| Net Margin (%) | -117.64 |
| Operating Margin % | 32.61 |
| Pre-tax Margin (%) | -119.95 |
| Quick Ratio | 0.48 |
| Current Ratio | 0.60 |
| ROA % (ttm) | -69.43 |
| ROE % (ttm) | -130.93 |
| ROIC % (ttm) | 21.26 |
| Dividend Yield % | -- |
| Altman Z-Score | -1.36 |
TKUNF Number of Guru Trades
TKUNF Volume of Guru Trades
Gurus Latest Trades with GREY:TKUNF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
GREY:TKUNF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Tikun Olam Cannbit Pharmaceuticals Ltd Insider Transactions
No Available Data
News about GREY:TKUNF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers